Literature DB >> 18823991

Testing on formalin-fixed neutrophils is less sensitive and specific for small vessel vasculitis, and less sensitive for MPO-ANCA, than most ELISAs.

Wendy Pollock1, Michelle Trevisin, Judy Savige.   

Abstract

This study evaluated the usefulness of testing sera with perinuclear antineutrophil cytoplasmic antibodies (P-ANCA) on formalin-fixed neutrophils to differentiate between vasculitis and other diseases, and to distinguish between myeloperoxidase (MPO) and other antigen targets. Sera from active (n=24) or treated vasculitis (n=23) and non-vasculitic disease (n=37) were tested in 3 ethanol- and 2 formalin-fixed neutrophil assays, and in 12 MPO-ANCA ELISAs. The sensitivity of demonstrating that P-ANCA became cytoplasmic on formalin-fixed cells in vasculitis, and negative in non-vasculitic disease was 75-79% in different assays compared with 88% for positivity in the majority of MPO-ANCA ELISAs. The sensitivity and specificity of demonstrating that P-ANCA became cytoplasmic where the target was MPO, and disappeared with other antigens were 89% and 74-80% respectively in different assays. P-ANCA specificity for MPO should be confirmed in one of the better-performing MPO-ANCA ELISAs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18823991     DOI: 10.1016/j.jim.2008.09.002

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

Review 1.  Laboratory investigation in the diagnosis of vasculitis.

Authors:  Luis Felipe Flores-Suárez
Journal:  Curr Rheumatol Rep       Date:  2009-12       Impact factor: 4.592

Review 2.  ANCA testing: the current stage and perspectives.

Authors:  Elena Csernok
Journal:  Clin Exp Nephrol       Date:  2012-11-23       Impact factor: 2.801

Review 3.  Twenty-eight years with antineutrophil cytoplasmic antibodies (ANCA): how to test for ANCA - evidence-based immunology?

Authors:  Elena Csernok; Julia U Holle
Journal:  Auto Immun Highlights       Date:  2010-07-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.